Influence of combined treatment of low dose rapamycin and cyclosporin A on corneal allograft survival

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 10, 2010, Pages 1447-1456

  Stanojlovic, Svetlana ^a   Schlickeiser, Stephan ^a   Appelt, Christine ^a   Vogt, Katrin ^a   Schmitt Knosalla, Isabela ^a   Haase, Stefanie ^a   Ritter, Thomas ^b   Sawitzki, Birgit ^a   Pleyer, Uwe ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Cornea; Immunomodulatory treatment; Transplantation

Indexed keywords

CD3 ANTIGEN; CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3; CYCLOSPORIN; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOMODULATION; INTERFERON PRODUCTION; LOW DRUG DOSE; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CORNEA; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECTS; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOID TISSUE; MALE; METABOLISM; PATHOLOGY; PENETRATING KERATOPLASTY;

ANIMALS; CORNEA; CYCLOSPORINE; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FLOW CYTOMETRY; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; KERATOPLASTY, PENETRATING; LYMPHOID TISSUE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIROLIMUS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 77956181782     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1420-z     Document Type: Article

References (57)

1. S McDonald G Russ S Campbell S Chadban 2007 Kidney transplant rejection in Australia and New Zealand: Relationships between rejection and graft outcome Am J Transplant 7 1201 1208 10.1111/j.1600-6143.2007.01759.x 17359502
2. G Opelz 1994 Effect of the maintenance immunosuppressive drug regiment on kidney transplant outcome Transplantation 58 443 446 10.1097/00007890- 199408270-00009 8073513
3. KA Williams AJ Esterman C Bartlett H Holland NB Hornsby DJ Coster 2006 How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis Transplantation 81 896 901 10.1097/01.tp.0000185197.37824.35 16570014
4. F Birnbaum D Böhringer Y Sokolovska R Sundmacher T Reinhard 2005 Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study Transplantation 79 964 968 10.1097/01.TP.0000158022.62059.F2 15849551
5. JC Hill 1994 Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy Ophthalmology 101 128 133 8302545
6. N Bailly I Dunewa P Schlattmann PW Rieck 2008 Significance of cyclosporin A absorption for effective immunomodulatory therapy after high-risk keratoplasty Ophthalmologe 105 457 462 10.1007/s00347-007-1632-8 18299847
7. AC Poon JE Forbes JK Dart S Subramaniam C Bunce P Madison LA Ficker SJ Tuft DS Gartry RJ Buckley 2001 Systemic cyclosporin A in high-risk penetrating keratoplasties: a case-control study Br J Ophthalmol 85 1464 1469 10.1136/bjo.85.12.1464 11734522
8. KC Inoue S Amano T Sato N Fujita F Kagaya Y Kaji T Tsuru M Araie 2001 Long-term outcome of systemic cyclosporine treatment following penetrating keratoplasty Jpn J Ophthalmol 45 378 382 10.1016/S0021-5155(01)00339-2 11485770
9. S Rumelt V Bersudsky T Blum-Hareuveni U Rehany 2002 Systemic cyclosporin A in high failure risk, repeated corneal transplantation Br J Ophthalmol 86 988 992 10.1136/bjo.86.9.988 12185123
10. SM Stepkowski L Tian KL Napoli R Ghobrial ME Wang TC Chou BD Kahan 1997 Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection Clin Exp Immunol 108 63 68 10.1046/j.1365-2249.1997. d01-984.x 9097913
11. H Chen J Wu H Luo P Daloze 1992 Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat Transplant Proc 3 892 893
12. P Thompson D Xu I Brunette H Chen 1998 Combined effect of rapamycin and cyclosporine in prevention of rat corneal allograft rejection Transplant Proc 30 1033 1035 10.1016/S0041-1345(98)00139-0 9636417
13. F Birnbaum A Reis D Böhringer Y Sokolowska K Mayer A Voiculescu M Oellerich R Sundmacher T Reinhard 2006 An open prospective pilot study on the use of rapamycin after penetrating high-risk keratoplasty Transplantation 81 767 772 10.1097/01.tp.0000191291.71003.1b 16534481
14. SN Sehgal 2003 Sirolimus: its discovery, biological properties and mechanism of action Transplant Proc 35 7 14 10.1016/S0041-1345(03)00211-2
15. RT Abraham GJ Wiederrecht 1996 Immunopharmacology of rapamycin Annu Rev Immunol 14 483 510 10.1146/annurev.immunol.14.1.483 8717522
16. GC Furtado AM Curotto de Lafaille N Kutchukhidze JJ Lafaille 2002 Interleukin 2 signalling is required for CD4(+) regulatory T cell function J Exp Med 196 851 857 10.1084/jem.20020190 12235217
17. M Battaglia A Stabilini MG Roncarolo 2005 Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells Blood 105 4743 4748 10.1182/blood-2004-10- 3932 15746082
18. JJ Coenen HJ Koenen E van Rijssen A Kasran L Boon LB Hilbrands I Joosten 2007 Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells Bone Marrow Transplant 39 537 545 10.1038/sj.bmt.1705628 17351648
19. L Tian L Lu Z Yuan JR Lamb PK Tam 2004 Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery Transplantation 77 183 189 10.1097/01.TP.0000101005.44661.3E 14742978
20. EP Zhang S Schründer F Hoffmann 1996 Orthotopic corneal transplantation in the mouse-a new surgical technique with minimal endothelial cell loss Graefes Arch Clin Exp Ophthalmol 234 714 719 10.1007/BF00292359 8950593
21. JY Niederkorn C Stevens J Mellon E Mayhew 2006 CD4+ T-cell-independent rejection of corneal allografts Transplantation 81 1171 1178 10.1097/01.tp.0000203140.70742.cb 16641604
22. DJ Coster KA Williams 2005 The impact of corneal allograft rejection on the long-term outcome of corneal transplantation Am J Ophthalmol 140 1112 1122 10.1016/j.ajo.2005.07.024 16376660
23. FW Price WE Whitson RG Marks 1991 Graft survival in four common groups of patients undergoing penetrating keratoplasty Ophthalmology 98 322 328 2023753
24. KA Williams D Roder A Esterman SM Muehlberg DJ Coster 1992 Factors predictive of corneal graft survival Ophthalmology 99 403 414 1565452
25. MN Scherer B Banas K Mantouvalou A Schnitzbauer A Obed BK Krämer HJ Schlitt 2007 Current concepts and perspectives of immunosuppression in organ transplantation Langenbecks Arch Surg 392 511 523 10.1007/s00423-007-0188-z 17450373
26. EP Zhang F Schulte S Bulfone-Paus F Hoffmann 2000 The effect of corticosteroid and cyclosporin A on murine corneal allograft rejection Graefes Arch Clin Exp Ophthalmol 238 525 530 10.1007/PL00007895 10943679
27. A Reis M Megahed T Reinhard C Braunstein E Godehardt R Sundmacher 2001 RAD, a new immunosuppressive macrolide in murine corneal transplantation Graefes Arch Clin Exp Ophthalmol 239 689 692 10.1007/s004170100258 11688669
28. I Claerhout H Beele A Verstraete C Van den Broecke P Kestelyn 2001 The effect of duration and timing of systemic cyclosporine therapy on corneal allograft survival in a rat model Graefes Arch Clin Exp Ophthalmol 239 152 157 10.1007/s004170000242 11372546
29. NR Brook JR Waller GR Bicknell ML Nicholson 2005 Cyclosporine and rapamycin act in a synergistic and dose-dependent manner in a model of immunosuppressant-induced kidney damage Transplant Proc 37 837 838 10.1016/j.transproceed.2004.12.147 15848549
30. C Beauregard C Stevens E Mayhew JY Niederkorn 2005 Cutting edge: Atopy promotes Th2 responses to alloantigens and increases the incidence and tempo of corneal allograft rejection J Immunol 174 6577 6581 15905494
31. JY Niederkorn 2007 Immune mechanisms of corneal allograft rejection Curr Eye Res 32 1005 1016 10.1080/02713680701767884 18085464
32. S Hargrave Y Chu D Mendelblatt E Mayhew J Niederkorn 2003 Preliminary findings in corneal allograft rejection in patients with keratoconus Am J Ophthalmol 135 452 460 10.1016/S0002-9394(02)02055-X 12654360
33. SL Hargrave C Hay J Mellon E Mayhew JY Niederkorn 2004 Fate of MHC-matched corneal allografts in Th1-deficient hosts Invest Ophthalmol Vis Sci 45 1188 1193 10.1167/iovs.03-0515 15037587
34. EM Chong MR Dana 2008 Graft failure IV. Immunologic mechanisms of corneal transplant rejection Int Ophthalmol 28 209 222 10.1007/s10792-007-9099-9 17673946
35. JY Niederkorn C Stevens J Mellon E Mayhew 2006 Differential roles of CD8+ and CD8- T lymphocytes in corneal allograft rejection in 'high-risk' hosts Am J Transplant 6 705 713 10.1111/j.1600-6143.2006.01237.x 16539627
36. Y Sonoda Y Sano B Ksander JW Streilein 1995 Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice Invest Ophthalmol Vis Sci 36 427 434 7843911
37. N Gong U Pleyer J Yang K Vogt M Hill I Anegon HD Volk T Ritter 2006 Influence of local and systemic CTLA4Ig gene transfer on corneal allograft survival J Gene Med 8 459 467 10.1002/jgm.876 16475216
38. U Pleyer E Bertelmann P Rieck C Hartmann HD Volk T Ritter 2000 Survival of corneal allografts following adenovirus-mediated gene transfer of interleukin-4 Graefes Arch Clin Exp Ophthalmol 238 531 536 10.1007/PL00007896 10943680
39. Y Qu B Zhang L Zhao G Liu H Ma E Rao C Zeng Y Zhao 2007 The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice Transpl Immunol 17 153 161 10.1016/j.trim.2007.01.002 17331841
40. H Wang L Zhao Z Sun L Sun B Zhang Y Zhao 2006 A potential side effect of cyclosporin A: inhibition of CD4(+)CD25(+) regulatory T cells in mice Transplantation 82 1484 1492 10.1097/01.tp.0000246312.89689.17 17164721
41. M Kawai H Kitake C Mathieu M Waer J Pirenne 2005 Inhibitory and stimulatory effects of cyclosporin A on the development of regulatory T cells in vivo Transplantation 79 1073 1077 10.1097/01.TP.0000153505.73700.32 15880046
42. S Wang J Jiang Q Guan Z Lan H Wang CY Nguan AM Jevnikar C Du 2008 Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model Transpl Immunol 19 93 102 10.1016/j.trim.2008.03.004 18503884
43. KG Haanstra JA Wubben SS Korevaar I Kondova CC Baan M Jonker 2007 Expression patterns of regulatory T-cell markers in accepted and rejected nonhuman primate kidney allografts Am J Transplant 7 2236 2246 10.1111/j.1600-6143.2007.01917.x 17845559
44. L Graca SP Cobbold H Waldmann 2002 Identification of regulatory T cells in tolerated allografts J Exp Med 195 1641 1646 10.1084/jem.20012097 12070291
45. SK Chauhan DR Saban HK Lee R Dana 2009 Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation J Immunol 182 148 153 19109145
46. S Bunnag K Allanach GS Jhangri B Sis G Einecke M Mengel TF Mueller PF Halloran 2008 FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes Am J Transplant 8 1423 1433 10.1111/j.1600-6143.2008.02268.x 18510637
47. M Hara CI Kingsley M Niimi S Read SE Turvey AR Bushell PJ Morris F Powrie KJ Wood 2001 IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo J Immunol 166 3789 3796 11238621
48. JC Ochando AC Yopp Y Yang A Garin Y Li P Boros J Llodra Y Ding SA Lira NR Krieger JS Bromberg 2005 Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells J Immunol 174 6993 7005 15905542
49. MA Schneider JG Meingassner M Lipp HD Moore A Rot 2007 CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells J Exp Med 204 735 745 10.1084/jem.20061405 17371928
50. JY Niederkorn J Mellon 1996 Anterior chamber-associated immune deviation promotes corneal allograft survival Invest Ophthalmol Vis Sci 37 13 2700 2707 8977485
51. JY Niederkorn 1999 The immune privilege of corneal allografts Transplantation 67 1503 1508 10.1097/00007890-199906270-00001 10401754
52. JW Streilein 1996 Ocular immune privilege and the Faustian dilemma. The Proctor lecture Invest Ophthalmol Vis Sci 37 1940 1950 8814133
53. JW Streilein JY Niederkorn 1981 Induction of anterior chamber-associated immune deviation requires an intact, functional spleen J Exp Med 153 1058 1067 10.1084/jem.153.5.1058 6788883
54. J Plsková L Duncan V Holán M Filipec G Kraal JV Forrester 2002 The immune response to corneal allograft requires a site-specific draining lymph node Transplantation 73 210 215 10.1097/00007890-200201270-00010 11821732
55. S Yamagami MR Dana 2001 The critical role of lymph nodes in corneal alloimmunization and graft rejection Invest Ophthalmol Vis Sci 42 1293 1298 11328742
56. XX Zheng A Sanchez-Fueyo C Domenig TB Strom 2003 The balance of deletion and regulation in allograft tolerance Immunol Rev 196 75 84 10.1046/j.1600-065X. 2003.00089.x 14617199
57. A Sánchez-Fueyo M Weber C Domenig TB Strom XX Zheng 2002 Tracking the immunoregulatory mechanisms active during allograft tolerance J Immunol 168 2274 2281 11859115